Preoperative Chemoradiotherapy for Rectal Cancer: Randomized Trial Comparing Oral Uracil and Tegafur and Oral Leucovorin Vs. Intravenous 5-Fluorouracil and Leucovorin

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 1, 2008, Pages 102-110

  de la Torre, Alejandro ^a   García Berrocal, Maria Isabel ^a   Arias, Fernando ^b   Mariño, Alfonso ^c   Valcárcel, Francisco ^a   Magallón, Rosa ^a   Regueiro, Carlos A ^a   Romero, Jesús ^a   Zapata, Irma ^a   de la Fuente, Cristina ^a   Fernández Lizarbe, Eva ^a   Vergara, Gloria ^a   Belinchón, Belén ^a   Veiras, Maria ^a   Molerón, Rafael ^a   Millán, Isabel ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c Centro Oncologico de Galicia   (Spain)

Author keywords

5 fluorouracil; Preoperative chemoradiation; Randomized trial; Rectal cancer; UFT

Indexed keywords

CHEMOTHERAPY; PATHOLOGY; PATIENT MONITORING; RADIOTHERAPY; TOXICITY;

5-FLUOROURACIL; PREOPERATIVE CHEMORADIATION; RANDOMIZED TRIALS; RECTAL CANCER;

ONCOLOGY;

FLUOROURACIL; FOLINIC ACID; UFT;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR; URACIL; VITAMIN B COMPLEX;

EID: 37049017365     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.068     Document Type: Article

References (49)

1. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
2. Kollmorgen C.F., Meagher A.P., Wolff B.G., et al. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 220 (1994) 676-682
3. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336 (1997) 980-987
4. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
5. Valentini V., Coco C., Cellini N., et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 40 (1998) 1067-1075
6. Bosset J.F., Magnin V., Maingon P., et al. Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 46 (2000) 323-327
7. Crane C.H., Skibber J.M., Birnbaum E.H., et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57 (2003) 84-89
8. Chan A., Wong A., Langevin J., et al. Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 25 (1993) 791-799
9. Gerard J.P., Chapet O., Nemoz C., et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol 21 (2003) 1119-1124
10. Janjan N.A., Crane C.N., Feig B.W., et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 47 (2000) 713-718
11. Brown C.L., Ternent C.A., Thorson A.G., et al. Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 46 (2003) 1189-1193
12. De la Torre A., Ramos S., Valcarcel F.J., et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys 45 (1999) 629-634
13. Bosset J.F., Pavy J.J., Hamers H.P., et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies. EORTC Radiotherapy Group. Eur J Cancer 29A (1993) 1406-1410
14. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 54 (1958) 457-481
15. Gooley T.A., Leisenring W., Crowley J., et al. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18 (1999) 695-706
16. Rich T., Gunderson L.L., Lew R., et al. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 52 (1983) 1317-1329
17. Mendenhall W.M., Million R.R., and Pfaff W.W. Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: Implications in treatment planning with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 9 (1983) 977-985
18. Pilipshen S.J., Heilweil M., Quan S.H., et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53 (1984) 1354-1362
19. Mendenhall W.M., Million R.R., Bland K.I., et al. Initially unresectable rectal adenocarcinoma treated with preoperative irradiation and surgery. Ann Surg 205 (1987) 41-44
20. Fortier G.A., Constable W.C., Meyers H., et al. Preoperative radiation therapy for rectal cancer. An effective therapy in need of a clinical trial. Arch Surg 121 (1986) 1380-1385
21. Dosoretz D.E., Gunderson L.L., Hedberg S., et al. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer 52 (1983) 814-818
22. Mohiuddin M., and Marks G. High dose preoperative irradiation for cancer of the rectum, 1976-1988. Int J Radiat Oncol Biol Phys 20 (1991) 37-43
23. Emami B., Pilepich M., Willett C., et al. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys 8 (1982) 1295-1299
24. Douglass Jr. H.O., Moertel C.G., Mayer R.J., et al. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315 (1986) 1294-1295
25. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324 (1991) 709-715
26. Smalley S.R., Benedetti J., Williamson S., et al. Intergroup 0144-phase III trial of 5-FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer: Bolus 5-FU vs prolonged venous infusion (PVI) before and after XRT + PVI vs bolus 5-FU + leucovorin (LV) + levamisole (LEV) before and after XRT + bolus 5-FU + LV. J Clin Oncol 22 (2003) 251
27. Frykholm G.J., Pahlman L., and Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 50 (2001) 427-434
28. Gerard J., Bonnetain F., Conroy T., et al. Pre-operative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3-T4 rectal cancers: results of the FFCD 9203 randomized trial. J Clin Oncol (Proc ASCO) 23 (2005) 247s
29. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
30. Liu G., Franssen E., Fitch M.I., et al. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15 (1997) 110-115
31. Borner M.M., Schoffski P., de Wit R., et al. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectal cancer. Eur J Cancer 38 (2002) 349-358
32. Sulkes A., Benner S.E., and Canetta R.M. Uracil-ftorafur: An oral fluoropyrimidine active in colorectal cancer. J Clin Oncol 16 (1998) 3461-3475
33. Diaz-Gonzalez J.A., Calvo F.A., Cortes J., et al. Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1378-1384
34. Pentheroudakis G., and Twelves C. The rational development of capecitabine from the laboratory to the clinic. Anticancer Res 22 (2002) 3589-3596
35. Van Cutsem E., Twelves C., Cassidy J., et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol 19 (2001) 4097-4106
36. Hoff P.M., Ansari R., Batist G., et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. J Clin Oncol 19 (2001) 2282-2292
37. Lembersky B.C., Wieand H.S., Petrelli N.J., et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol 24 (2006) 2059-2064
38. Saltz L.B., Cox J.V., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343 (2000) 905-914
39. de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
40. Rödel C., Liersch T., Hermann R.M., et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 25 (2007) 110-117
41. Mohiuddin M., Winter K., Mitchell E., et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 24 (2006) 650-655
42. Willett C.G., Chung D., Sahani D., et al. Phase I study of neoadjuvant bevacizumab, 5-fluorouracil, and radiation therapy followed by surgery for patients with primary rectal cancer. J Clin Oncol 22 Suppl (2006) 3589
43. Calvo F.A., Serrano F.J., Diaz-Gonzalez J.A., et al. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation. Ann Oncol 17 (2006) 1103-1110
44. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
45. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72 (2004) 15-24
46. Fernandez-Martos C., Aparicio J., Bosch C., et al. Preoperative uracil/tegafur and concomitant radiotherapy in locally advanced rectal cancer: Updated results with 5-year follow-up. J Clin Oncol 24 Suppl (2006) 3573
47. Lin E.H., Skibber J., Delclos M., et al. A phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer. J Clin Oncol 23 (2005) 3593
48. Kim J.C., Kim T.W., Kim J.H., et al. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 346-353
49. De Paoli A., Chiara S., Luppi G., et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: A multicentric phase II study. Ann Oncol 17 (2006) 246-251